Filed before 2025Filed 3 January 2012
Miragen Therapeutics Inc has sold $6M so far
Miragen Therapeutics Inc, a biotech company based in Boulder, CO, has sold $6M so far in its convertible round, according to a filing dated 3 January 2012.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 3 January 2012
- Round
- Convertible round (amended filing)
- Amount sold
- $6M
- Offering size
- $6M
- Investors so far
- 24
- Based in
- Boulder, CO
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 61% of the 368 tracked raises with an amount filed in 2012, and than 62% of the 32 in biotech.
Miragen Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 14 Feb 2017 | New filing | $40.7M | Another raise |
| 12 Nov 2015 | New filing | $25M | Another raise |
| 17 Feb 2015 | New filing | $8.5M | Another raise |
| 26 Jun 2014 | Amended filing | $13M | Another raise |
| 3 Jan 2012 | Amended filing | $6M | This raise |
More with Boulder Ventures on the board
- Synaptic Era Inc.$2.05M
- Opanga Networks, Inc.$200K
- Ambrosia Biosciences Inc.$16M
- Adwerx, Inc.$5.78M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.